Brief: Organovo Announces Target Validation Ahead Of Schedule, Accelerating Timeline For First Crohn’S Disease Drug Candidates

VivoSim Labs

15/11/2022 13:25

Nov 15 (Reuters) - Organovo Holdings Inc  ONVO.O :
    * ORGANOVO ANNOUNCES TARGET VALIDATION AHEAD OF SCHEDULE,
ACCELERATING TIMELINE FOR FIRST CROHN’S DISEASE DRUG CANDIDATES
    * ORGANOVO HOLDINGS-PLANS TO ADVANCE AT LEAST ONE TARGET
PROGRAM
TO MEDICINAL CHEMISTRY BY END OF 2022 TO BUILD PROPRIETARY NEW
DRUG FOR CROHN'S DISEASE

Source text for Eikon:  ID:nGNX2K3B4Q 
Further company coverage:  ONVO.O